1-Ethyl-N-(1-methylcyclopropyl)-3-[(1-methylpyrazol-4-yl)methyl]-2,4-dioxo-quinazoline-6-sulfonamide

ID: ALA4282082

Chembl Id: CHEMBL4282082

PubChem CID: 121398732

Max Phase: Preclinical

Molecular Formula: C19H23N5O4S

Molecular Weight: 417.49

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCn1c(=O)n(Cc2cnn(C)c2)c(=O)c2cc(S(=O)(=O)NC3(C)CC3)ccc21

Standard InChI:  InChI=1S/C19H23N5O4S/c1-4-23-16-6-5-14(29(27,28)21-19(2)7-8-19)9-15(16)17(25)24(18(23)26)12-13-10-20-22(3)11-13/h5-6,9-11,21H,4,7-8,12H2,1-3H3

Standard InChI Key:  VDNPAHSYCDBDLA-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4282082

    ---

Associated Targets(Human)

PARG Tchem Poly(ADP-ribose) glycohydrolase (228 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 417.49Molecular Weight (Monoisotopic): 417.1471AlogP: 0.80#Rotatable Bonds: 6
Polar Surface Area: 107.99Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 9.88CX Basic pKa: 1.94CX LogP: 0.92CX LogD: 0.92
Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.64Np Likeness Score: -1.83

References

1. Waszkowycz B, Smith KM, McGonagle AE, Jordan AM, Acton B, Fairweather EE, Griffiths LA, Hamilton NM, Hamilton NS, Hitchin JR, Hutton CP, James DI, Jones CD, Jones S, Mould DP, Small HF, Stowell AIJ, Tucker JA, Waddell ID, Ogilvie DJ..  (2018)  Cell-Active Small Molecule Inhibitors of the DNA-Damage Repair Enzyme Poly(ADP-ribose) Glycohydrolase (PARG): Discovery and Optimization of Orally Bioavailable Quinazolinedione Sulfonamides.,  61  (23): [PMID:30403352] [10.1021/acs.jmedchem.8b01407]
2. Acton B, Small HF, Smith KM, McGonagle A, Stowell AIJ, James DI, Hamilton NM, Hamilton N, Hitchin JR, Hutton CP, Waddell ID, Ogilvie DJ, Jordan AM..  (2019)  Fluoromethylcyclopropylamine derivatives as potential in vivo toxicophores - A cautionary disclosure.,  29  (4): [PMID:30616904] [10.1016/j.bmcl.2018.12.066]

Source